In the future, prospective longitudinal studies and basic research, especially tissue-specific knockout studies of RCAN2, are needed to confirm the role of RCAN2 in the development of NAFLD. This evidence concerns the gene RCAN2 and metabolic dysfunction-associated steatotic liver disease.